TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
MGNX

MacroGenics Inc

Healthcare · Biotechnology

4.10$ +0.2% vs. previous close Closing price · As of: Sep 18, 2026

Ownership

Ownership Structure

Who owns MacroGenics Inc (MGNX)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 88.6% of the shares are freely tradable; institutional investors hold 70.3%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 70.3%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 3.4%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 88.6%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 11.6%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 64Mio.

Largest Shareholders

Institutions

Institutions MGNX
Name Stake (%) Shares Change (%) Date
Armistice Capital, LLC 9.46 6,012,000 -4.9 03/31/2026
Renaissance Technologies Corp 4.66 2,963,559 +1.9 03/31/2026
Vanguard Capital Management, LLC 4.18 2,653,853 +0.0 03/31/2026
Acadian Asset Management LLC 4.00 2,544,000 +199,116.9 03/31/2026
Two Sigma Investments LLC 3.88 2,465,699 -2.5 06/30/2026
Bank of America Corp 3.78 2,401,814 +30.7 03/31/2026
Millennium Management LLC 3.74 2,374,296 -15.0 06/30/2026
Marshall Wace Asset Management Ltd 3.19 2,025,526 +57.7 03/31/2026
Wasatch Advisors LP 3.18 2,018,881 +29.4 06/30/2026

Funds

Funds MGNX
Name Stake (%) Shares Change (%) Date
Vanguard MStar Total Stk Mkt Idx Invest 3.03 1,925,510 +0.0 07/31/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Insider holdings

Insider holdings MGNX
Person Role Shares Value As of Type
Bonvini Ezio Sr VP, Research & CSO 185,799 761,776 $ Aug 17, 2026 direct

Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.

Insiders

Insider Transactions

Insider Transactions
Date Person Role Type Shares Price Value
Aug 19, 2026 Peters Jeffrey Stuart Senior VP, GC, and Secretary Sell 31,105 4.15 129,086
Aug 17, 2026 Bonvini Ezio Sr VP, Research & CSO Other 40,000 2.60 104,000

Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?